KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme Group (CME) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to 64.97%.

  • Cme Group's EBITDA Margin fell 145.00% to 64.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.25%, marking a year-over-year increase of 115.00%. This contributed to the annual value of 64.13% for FY2024, which is 255.00% up from last year.
  • Per Cme Group's latest filing, its EBITDA Margin stood at 64.97% for Q3 2025, which was down 4.95% from 68.36% recorded in Q2 2025.
  • Over the past 5 years, Cme Group's EBITDA Margin peaked at 69.13% during Q1 2025, and registered a low of 55.06% during Q4 2021.
  • For the 3-year period, Cme Group's EBITDA Margin averaged around 65.26%, with its median value being 65.59% (2023).
  • Within the past 5 years, the most significant YoY rise in Cme Group's EBITDA Margin was 818bps (2021), while the steepest drop was 453bps (2021).
  • Over the past 5 years, Cme Group's EBITDA Margin (Quarterly) stood at 55.06% in 2021, then climbed by 27bps to 55.33% in 2022, then soared by 464bps to 59.97% in 2023, then spiked by 212bps to 62.09% in 2024, then slumped by 145bps to 64.97% in 2025.
  • Its EBITDA Margin was 64.97% in Q3 2025, compared to 68.36% in Q2 2025 and 69.13% in Q1 2025.